Gunn & Company Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$3.05M Sell
26,882
-308,380
-92% -$36.6M 2.1% 21
2024
Q2
$41.5M Buy
335,262
+308,785
+1,166% +$39.8M 2.46% 15
2024
Q1
$3.49M Sell
26,477
-307,266
-92% -$37.9M 2.63% 14
2023
Q4
$36.4M Buy
333,743
+307,780
+1,185% +$31.9M 2.4% 20
2023
Q3
$2.67M Buy
+25,963
New +$2.8M 2.35% 18

Other funds holding MRK

Gunn & Company Investment Management's MRK Position: Q3 2024 in Review

Gunn & Company Investment Management reduced its Merck (MRK) stake by 92% in Q3 2024, selling an estimated $36.6M and leaving 26,882 shares worth $3.05M. The position accounts for 2.1% of the portfolio, ranked #21.

Gunn & Company Investment Management first reported a position in MRK in Q3 2023 and has held it in 5 quarters since. The position peaked at $41.5M in Q2 2024. 3,491 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Gunn & Company Investment Management held 26,882 shares of Merck worth $3.05M as of Q3 2024.
  • Gunn & Company Investment Management sold 308,380 Merck shares in Q3 2024, an estimated $36.6M.
  • Merck made up 2.1% of Gunn & Company Investment Management's portfolio in Q3 2024, its #21 holding.
  • Gunn & Company Investment Management first reported a position in Merck in Q3 2023 and has held it in 5 quarters since.
  • Gunn & Company Investment Management's Merck position peaked at $41.5M in Q2 2024.
  • 3,491 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Gunn & Company Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.